| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | ZNF385D ZFAND3 SETDB2 RARA RARB MID2 MBD1 MID1 TRIM49D1 ADAM33 NR1D1 ZFYVE1 TRIM48 | 1.88e-06 | 891 | 60 | 13 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | ZNF385D ZFAND3 SETDB2 RARA RARB MID2 MBD1 MID1 TRIM49D1 FAXDC2 ADAM33 NR1D1 ZFYVE1 TRIM48 | 8.56e-06 | 1189 | 60 | 14 | GO:0046914 |
| GeneOntologyMolecularFunction | laminin binding | 1.44e-04 | 34 | 60 | 3 | GO:0043236 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | RARA MID2 NDC80 TRPM7 TTLL9 MID1 TUBGCP3 MACF1 PLEKHH2 FXYD1 MYO16 | 3.81e-04 | 1099 | 60 | 11 | GO:0008092 |
| GeneOntologyMolecularFunction | nuclear receptor activity | 7.81e-04 | 60 | 60 | 3 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 8.20e-04 | 61 | 60 | 3 | GO:0098531 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 9.09e-04 | 15 | 60 | 2 | GO:0051011 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.38e-03 | 73 | 60 | 3 | GO:0050840 | |
| Domain | SEA | 4.20e-05 | 22 | 58 | 3 | PF01390 | |
| Domain | SEA | 4.82e-05 | 23 | 58 | 3 | PS50024 | |
| Domain | SEA_dom | 4.82e-05 | 23 | 58 | 3 | IPR000082 | |
| Domain | Retinoic_acid_rcpt | 5.66e-05 | 4 | 58 | 2 | IPR003078 | |
| Domain | BBOX | 6.23e-05 | 69 | 58 | 4 | SM00336 | |
| Domain | Butyrophylin | 6.59e-05 | 70 | 58 | 4 | IPR003879 | |
| Domain | - | 6.97e-05 | 71 | 58 | 4 | 4.10.45.10 | |
| Domain | zf-B_box | 7.36e-05 | 72 | 58 | 4 | PF00643 | |
| Domain | ZF_BBOX | 1.11e-04 | 80 | 58 | 4 | PS50119 | |
| Domain | Znf_B-box | 1.17e-04 | 81 | 58 | 4 | IPR000315 | |
| Domain | EGF-like_CS | 1.55e-04 | 261 | 58 | 6 | IPR013032 | |
| Domain | SPRY | 2.07e-04 | 94 | 58 | 4 | PF00622 | |
| Domain | SPRY_dom | 2.07e-04 | 94 | 58 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 2.16e-04 | 95 | 58 | 4 | IPR001870 | |
| Domain | B302_SPRY | 2.16e-04 | 95 | 58 | 4 | PS50188 | |
| Domain | - | 2.62e-04 | 8 | 58 | 2 | 3.30.890.10 | |
| Domain | zf-C4 | 3.92e-04 | 46 | 58 | 3 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 3.92e-04 | 46 | 58 | 3 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 3.92e-04 | 46 | 58 | 3 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 3.92e-04 | 46 | 58 | 3 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 3.92e-04 | 46 | 58 | 3 | PS00031 | |
| Domain | ZnF_C4 | 3.92e-04 | 46 | 58 | 3 | SM00399 | |
| Domain | - | 4.18e-04 | 47 | 58 | 3 | 1.10.565.10 | |
| Domain | HOLI | 4.45e-04 | 48 | 58 | 3 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 4.45e-04 | 48 | 58 | 3 | IPR000536 | |
| Domain | Hormone_recep | 4.45e-04 | 48 | 58 | 3 | PF00104 | |
| Domain | Methyl_CpG_DNA-bd | 5.12e-04 | 11 | 58 | 2 | IPR001739 | |
| Domain | MBD | 5.12e-04 | 11 | 58 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 5.12e-04 | 11 | 58 | 2 | IPR016177 | |
| Domain | MBD | 5.12e-04 | 11 | 58 | 2 | SM00391 | |
| Domain | MBD | 5.12e-04 | 11 | 58 | 2 | PS50982 | |
| Domain | ConA-like_dom | 5.85e-04 | 219 | 58 | 5 | IPR013320 | |
| Domain | COS_domain | 6.13e-04 | 12 | 58 | 2 | IPR017903 | |
| Domain | COS | 6.13e-04 | 12 | 58 | 2 | PS51262 | |
| Domain | - | 7.38e-04 | 57 | 58 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 7.77e-04 | 58 | 58 | 3 | IPR013088 | |
| Domain | SEA | 8.42e-04 | 14 | 58 | 2 | SM00200 | |
| Domain | Bbox_C | 9.70e-04 | 15 | 58 | 2 | IPR003649 | |
| Domain | BBC | 9.70e-04 | 15 | 58 | 2 | SM00502 | |
| Domain | - | 9.70e-04 | 15 | 58 | 2 | 3.40.33.10 | |
| Domain | CAP | 9.70e-04 | 15 | 58 | 2 | PF00188 | |
| Domain | CAP_domain | 9.70e-04 | 15 | 58 | 2 | IPR014044 | |
| Domain | - | 9.70e-04 | 15 | 58 | 2 | 3.30.70.960 | |
| Domain | SCP | 9.70e-04 | 15 | 58 | 2 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 9.70e-04 | 15 | 58 | 2 | IPR001283 | |
| Domain | EGF_1 | 1.16e-03 | 255 | 58 | 5 | PS00022 | |
| Domain | EGF_2 | 1.37e-03 | 265 | 58 | 5 | PS01186 | |
| Domain | Integrin_alpha-2 | 1.40e-03 | 18 | 58 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 1.40e-03 | 18 | 58 | 2 | PF08441 | |
| Domain | Integrin_alpha | 1.40e-03 | 18 | 58 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 1.40e-03 | 18 | 58 | 2 | PS00242 | |
| Domain | Int_alpha_beta-p | 1.57e-03 | 19 | 58 | 2 | IPR013519 | |
| Domain | Int_alpha | 1.57e-03 | 19 | 58 | 2 | SM00191 | |
| Domain | fn3 | 1.61e-03 | 162 | 58 | 4 | PF00041 | |
| Domain | FG_GAP | 2.10e-03 | 22 | 58 | 2 | PS51470 | |
| Domain | ZF_RING_2 | 2.30e-03 | 298 | 58 | 5 | PS50089 | |
| Domain | NACHT | 2.30e-03 | 23 | 58 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 2.30e-03 | 23 | 58 | 2 | IPR007111 | |
| Domain | FG-GAP | 2.50e-03 | 24 | 58 | 2 | PF01839 | |
| Domain | FG-GAP | 2.50e-03 | 24 | 58 | 2 | IPR013517 | |
| Domain | SPRY | 2.50e-03 | 87 | 58 | 3 | SM00449 | |
| Domain | RING | 2.54e-03 | 305 | 58 | 5 | SM00184 | |
| Domain | FN3 | 2.61e-03 | 185 | 58 | 4 | SM00060 | |
| Domain | - | 2.63e-03 | 449 | 58 | 6 | 3.30.40.10 | |
| Domain | Integrin_dom | 2.72e-03 | 25 | 58 | 2 | IPR032695 | |
| Domain | Znf_RING/FYVE/PHD | 2.93e-03 | 459 | 58 | 6 | IPR013083 | |
| Domain | TIMP-like_OB-fold | 2.94e-03 | 26 | 58 | 2 | IPR008993 | |
| Domain | Galactose-bd-like | 3.12e-03 | 94 | 58 | 3 | IPR008979 | |
| Pubmed | Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation. | 2.93e-06 | 2 | 60 | 2 | 29921692 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 24833708 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 15159591 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 30601638 | ||
| Pubmed | Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome. | 2.93e-06 | 2 | 60 | 2 | 26788540 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 7644503 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 1330302 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 27306217 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 9168777 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 12009305 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 1334013 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 9852056 | ||
| Pubmed | Differential expression of retinoic acid receptors in normal and malignant esophageal tissues. | 8.77e-06 | 3 | 60 | 2 | 15255287 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 7607068 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 7607067 | ||
| Pubmed | Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. | 8.77e-06 | 3 | 60 | 2 | 17244680 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 11172439 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 8383767 | ||
| Pubmed | The molecular and genetic dissection of the retinoid signalling pathway. | 8.77e-06 | 3 | 60 | 2 | 8276261 | |
| Pubmed | Retinoic acid receptor gamma: specific immunodetection and phosphorylation. | 8.77e-06 | 3 | 60 | 2 | 1655807 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 15831518 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 17252005 | ||
| Pubmed | Immunolocalization of retinoic acid receptors in rat, mouse and human ovary and uterus. | 8.77e-06 | 3 | 60 | 2 | 8136307 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 8626453 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 24357724 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 8388780 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 9659935 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 7910825 | ||
| Pubmed | Tissue-specific expression of retinoic acid receptor isoform transcripts in the mouse embryo. | 8.77e-06 | 3 | 60 | 2 | 10842077 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 8027572 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 11806752 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 11245412 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 23969901 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 2544807 | ||
| Pubmed | [Genetic expression and morphogenesis of the skin in vertebrates]. | 8.77e-06 | 3 | 60 | 2 | 8099268 | |
| Pubmed | Regulation of retinoic acid receptor alpha by protein kinase C in B16 mouse melanoma cells. | 8.77e-06 | 3 | 60 | 2 | 12000751 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 10100049 | ||
| Pubmed | Specificity of retinoid receptor gene expression in mouse cervical epithelia. | 8.77e-06 | 3 | 60 | 2 | 8156902 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 9699718 | ||
| Pubmed | Mammalian hexokinase 1: evolutionary conservation and structure to function analysis. | 8.77e-06 | 3 | 60 | 2 | 1783373 | |
| Pubmed | Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. | 8.77e-06 | 3 | 60 | 2 | 1283441 | |
| Pubmed | Characterization of retinoic acid receptor-deficient keratinocytes. | 8.77e-06 | 3 | 60 | 2 | 10748128 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 36446525 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 2737701 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 15528208 | ||
| Pubmed | Immunohistochemical localization of the retinoic Acid receptors in human prostate. | 8.77e-06 | 3 | 60 | 2 | 12399530 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 29848550 | ||
| Pubmed | Association of retinoic acid receptor genes with meningomyelocele. | 8.77e-06 | 3 | 60 | 2 | 21254357 | |
| Pubmed | Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes. | 8.77e-06 | 3 | 60 | 2 | 1655630 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 19350571 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 24050824 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 12093741 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 7626396 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 8524212 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 17363914 | ||
| Pubmed | Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma. | 1.75e-05 | 4 | 60 | 2 | 22022577 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 7967725 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 11685209 | ||
| Pubmed | Biosynthesis and function of all-trans- and 9-cis-retinoic acid in parathyroid cells. | 1.75e-05 | 4 | 60 | 2 | 9005841 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 14691372 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 18845237 | ||
| Pubmed | The retinoic acid receptors RARalpha and RARgamma are required for inner ear development. | 1.75e-05 | 4 | 60 | 2 | 12464434 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 9376317 | ||
| Pubmed | Poly (ADP-ribose) glycohydrolase regulates retinoic acid receptor-mediated gene expression. | 1.75e-05 | 4 | 60 | 2 | 23102699 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 9348290 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 2556642 | ||
| Pubmed | Retinoic acid signalling in the development of branchial arches. | 1.75e-05 | 4 | 60 | 2 | 15380252 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 10869350 | ||
| Pubmed | 2.47e-05 | 199 | 60 | 5 | 23382691 | ||
| Pubmed | Retinoic acid signaling regulates murine bronchial tubule formation. | 2.92e-05 | 5 | 60 | 2 | 12834868 | |
| Pubmed | Retinoic acid signaling is necessary for the development of the organ of Corti. | 2.92e-05 | 5 | 60 | 2 | 10452855 | |
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 19665987 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 31097581 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 8152920 | ||
| Pubmed | The methyl-CpG binding protein MBD1 is required for PML-RARalpha function. | 2.92e-05 | 5 | 60 | 2 | 16432238 | |
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 1334737 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 9053308 | ||
| Pubmed | Vitamin A controls epithelial/mesenchymal interactions through Ret expression. | 2.92e-05 | 5 | 60 | 2 | 11138002 | |
| Pubmed | High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. | 2.92e-05 | 5 | 60 | 2 | 8394014 | |
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 9097025 | ||
| Pubmed | Retinal dysplasia and degeneration in RARbeta2/RARgamma2 compound mutant mice. | 2.92e-05 | 5 | 60 | 2 | 8681798 | |
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 8174226 | ||
| Pubmed | Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. | 2.92e-05 | 5 | 60 | 2 | 19006694 | |
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 19345331 | ||
| Pubmed | Distal ureter morphogenesis depends on epithelial cell remodeling mediated by vitamin A and Ret. | 2.92e-05 | 5 | 60 | 2 | 12195422 | |
| Pubmed | The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. | 4.37e-05 | 6 | 60 | 2 | 9806918 | |
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 1966045 | ||
| Pubmed | Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes. | 4.37e-05 | 6 | 60 | 2 | 11328745 | |
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 16434393 | ||
| Pubmed | A genetic dissection of the retinoid signalling pathway in the mouse. | 4.37e-05 | 6 | 60 | 2 | 10604193 | |
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 8563020 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 1849812 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 9153406 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 9590554 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 26522286 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 24699546 | ||
| Pubmed | Roles of retinoic acid receptors in early embryonic morphogenesis and hindbrain patterning. | 4.37e-05 | 6 | 60 | 2 | 11493525 | |
| Pubmed | Mesenchymal/epithelial regulation of retinoic acid signaling in the olfactory placode. | 4.37e-05 | 6 | 60 | 2 | 12941622 | |
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 8635876 | ||
| Pubmed | Spatial distributions of retinoic acid receptor gene transcripts in the prenatal mouse inner ear. | 4.37e-05 | 6 | 60 | 2 | 9548551 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 9.04e-05 | 95 | 45 | 4 | 59 | |
| GeneFamily | Nuclear hormone receptors | 2.45e-04 | 49 | 45 | 3 | 71 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 3.28e-04 | 11 | 45 | 2 | 1025 | |
| GeneFamily | Ring finger proteins | 5.83e-04 | 275 | 45 | 5 | 58 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 9.04e-04 | 18 | 45 | 2 | 1160 | |
| GeneFamily | NLR family | 1.75e-03 | 25 | 45 | 2 | 666 | |
| GeneFamily | Fibronectin type III domain containing | 7.35e-03 | 160 | 45 | 3 | 555 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.49e-06 | 160 | 60 | 5 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.68e-06 | 182 | 60 | 5 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 4.93e-06 | 184 | 60 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.06e-06 | 185 | 60 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.33e-06 | 187 | 60 | 5 | 1aebf6fab40b96f2f5feb77a302bb805838fccf3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.33e-06 | 187 | 60 | 5 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.76e-06 | 190 | 60 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.76e-06 | 190 | 60 | 5 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | mLN-T_cell-Th17|T_cell / Region, Cell class and subclass | 7.04e-06 | 198 | 60 | 5 | efdc9515dd9fb20ef9c8ddc106d88cbdde7d6ea2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.22e-06 | 199 | 60 | 5 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.39e-06 | 200 | 60 | 5 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.39e-06 | 200 | 60 | 5 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.39e-06 | 200 | 60 | 5 | c1797542541747b524c9c22c723d24c8d027d486 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.39e-06 | 200 | 60 | 5 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.39e-06 | 200 | 60 | 5 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.39e-06 | 200 | 60 | 5 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.39e-06 | 200 | 60 | 5 | a0cc84add181109bb66ba9d49c732e1790222c96 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.39e-06 | 200 | 60 | 5 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.38e-05 | 124 | 60 | 4 | ff08f74c3bc8e60679e0e21370095936a174c580 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.45e-05 | 125 | 60 | 4 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(3)_72hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 3.13e-05 | 133 | 60 | 4 | 32c6a00671af309c4b0b90e93549733729684c61 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-05 | 145 | 60 | 4 | 186b8bd8ac2d5c66cc29fdc2dd6751eddce3e8b8 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.98e-05 | 157 | 60 | 4 | beab0ac47202266b04543c02cfcdda012375e879 | |
| ToppCell | IIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type | 6.28e-05 | 159 | 60 | 4 | 55e4f21548f480ca414c00cbff5ec3b13bafd271 | |
| ToppCell | URO-Lymphocyte-T_NK-MAIT|URO / Disease, Lineage and Cell Type | 7.08e-05 | 164 | 60 | 4 | cb42a70433b3968caca67f7aa98ea536cd90a0bc | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.42e-05 | 166 | 60 | 4 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.95e-05 | 169 | 60 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-05 | 170 | 60 | 4 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-05 | 170 | 60 | 4 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-05 | 170 | 60 | 4 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | Pericytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.32e-05 | 171 | 60 | 4 | bbc8d9fc83d37c9250345b1e76776610799de9ae | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.70e-05 | 173 | 60 | 4 | 11e95a60b5f6f07f27154a23203bac431e7528c6 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.90e-05 | 174 | 60 | 4 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.90e-05 | 174 | 60 | 4 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.90e-05 | 174 | 60 | 4 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.90e-05 | 174 | 60 | 4 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.90e-05 | 174 | 60 | 4 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.90e-05 | 174 | 60 | 4 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.10e-05 | 175 | 60 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.30e-05 | 176 | 60 | 4 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.51e-05 | 177 | 60 | 4 | 91706bd0d4dda8d98843fb00b898d5aca4d66b64 | |
| ToppCell | Pericytes-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 9.72e-05 | 178 | 60 | 4 | a2448d868da2abe48c394c51264aad03e866dfec | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 180 | 60 | 4 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Adcyap1_(Dentate_hilum?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 67 | 60 | 3 | 52f6c244e8d89ccacb79bc5ef3663a5d01fd393c | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Adcyap1_(Dentate_hilum?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 67 | 60 | 3 | e462f9b5dca7c64101a31891f25654c05f2d215d | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 181 | 60 | 4 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 181 | 60 | 4 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 181 | 60 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 181 | 60 | 4 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-04 | 183 | 60 | 4 | b4f29dd3994009bb5eb769d36d95886664e7f87d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 183 | 60 | 4 | c7e94fe3e7669db9304b249979fef7a69c30a143 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 183 | 60 | 4 | 6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 183 | 60 | 4 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 183 | 60 | 4 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 185 | 60 | 4 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-04 | 185 | 60 | 4 | ef3c1fd52d21d96f81fb0e5097b24be0ce16e222 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.13e-04 | 185 | 60 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 185 | 60 | 4 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-04 | 185 | 60 | 4 | c357fa098b561da16c9fa82b0c3563b5cd3fa875 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 185 | 60 | 4 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 186 | 60 | 4 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 186 | 60 | 4 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-04 | 186 | 60 | 4 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 187 | 60 | 4 | b827d9da7032bf051756ddf88352af922eb0f87b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 187 | 60 | 4 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 187 | 60 | 4 | 61c00604dda8b36a5c3eea6554e5601aa1b884f7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 188 | 60 | 4 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 188 | 60 | 4 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.20e-04 | 188 | 60 | 4 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.20e-04 | 188 | 60 | 4 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 188 | 60 | 4 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 188 | 60 | 4 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.20e-04 | 188 | 60 | 4 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 189 | 60 | 4 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 189 | 60 | 4 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 189 | 60 | 4 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 189 | 60 | 4 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 189 | 60 | 4 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 189 | 60 | 4 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 189 | 60 | 4 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.22e-04 | 189 | 60 | 4 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 189 | 60 | 4 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 189 | 60 | 4 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-04 | 190 | 60 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 190 | 60 | 4 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 190 | 60 | 4 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 190 | 60 | 4 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-04 | 191 | 60 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-04 | 191 | 60 | 4 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 191 | 60 | 4 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.27e-04 | 191 | 60 | 4 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 60 | 4 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 191 | 60 | 4 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 60 | 4 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 191 | 60 | 4 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 60 | 4 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-04 | 192 | 60 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 1.30e-04 | 192 | 60 | 4 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-04 | 192 | 60 | 4 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-04 | 192 | 60 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| Drug | Ro 8-8717 | 6.60e-06 | 2 | 59 | 2 | CID006438148 | |
| Drug | Tamibarotene | 6.60e-06 | 2 | 59 | 2 | DB04942 | |
| Drug | Penbutolol sulfate [38363-32-5]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.06e-05 | 193 | 59 | 6 | 3534_UP | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 1.16e-05 | 196 | 59 | 6 | 7369_DN | |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 2.19e-05 | 4 | 57 | 2 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 2.19e-05 | 4 | 57 | 2 | C0751925 | |
| Disease | Lesion of Sciatic Nerve | 2.19e-05 | 4 | 57 | 2 | C0154748 | |
| Disease | Sciatic Neuritis | 2.19e-05 | 4 | 57 | 2 | C0242013 | |
| Disease | Sciatic Neuropathy | 2.19e-05 | 4 | 57 | 2 | C0149940 | |
| Disease | Opitz GBBB syndrome (implicated_via_orthology) | 5.47e-05 | 6 | 57 | 2 | DOID:0080697 (implicated_via_orthology) | |
| Disease | ubiquitin-like protein ISG15 measurement | 5.47e-05 | 6 | 57 | 2 | EFO_0021875 | |
| Disease | susceptibility to common cold measurement | 1.58e-04 | 54 | 57 | 3 | EFO_0008417 | |
| Disease | cup-to-disc ratio measurement | 1.79e-04 | 430 | 57 | 6 | EFO_0006939 | |
| Disease | FEV change measurement, response to bronchodilator | 1.96e-04 | 58 | 57 | 3 | EFO_0005921, GO_0097366 | |
| Disease | tuberculin skin test reactivity measurement, decreased susceptibility to bacterial infection | 2.39e-04 | 12 | 57 | 2 | EFO_0008307, EFO_0008322 | |
| Disease | caudal anterior cingulate cortex volume measurement | 4.89e-04 | 17 | 57 | 2 | EFO_0010289 | |
| Disease | maximal midexpiratory flow rate | 6.81e-04 | 20 | 57 | 2 | EFO_0004313 | |
| Disease | economic and social preference | 8.86e-04 | 97 | 57 | 3 | EFO_0004827 | |
| Disease | reaction time measurement | 1.66e-03 | 658 | 57 | 6 | EFO_0008393 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ATCKINCNNFRLLQN | 1226 | Q5DID0 | |
| RKQIISCNICQLRFN | 76 | Q9H6B1 | |
| IQQCQQLHCLRVLSF | 1256 | Q13075 | |
| AARNILVNQNLCCKV | 751 | P21709 | |
| RNLQDLCRIKIRQCI | 276 | Q9H672 | |
| LCRIKIRQCIGLQNL | 281 | Q9H672 | |
| AFQNVLRIQCLCRKQ | 336 | P35348 | |
| NQAARKILLNCLCSF | 481 | Q9NXL2 | |
| CELQRAQCSQQRRIR | 221 | O00468 | |
| KIMTQRCNNRTQCIV | 91 | O95490 | |
| RCRKNAFQELQRCLT | 641 | Q9BZ11 | |
| LLVQVCQFSNVLRKQ | 141 | Q9NR19 | |
| IINKVTRNRCQYCRL | 131 | P10276 | |
| VINKVTRNRCQYCRL | 131 | P10826 | |
| CRLVNRPQSILNCIN | 96 | Q8IXN7 | |
| QAQQVQRIISRCNCR | 1696 | Q14667 | |
| CLDNLCVNRQRDQVK | 201 | P48060 | |
| NDLCLQLQRKIITCQ | 1141 | Q9Y6X6 | |
| KTLRQCQEQRQCHCR | 116 | Q9UHD0 | |
| QCLQDSLIRLQCNHK | 756 | P98073 | |
| CRQDQRAVAVCNLQK | 431 | Q96KR4 | |
| CVLVSIRNNRNLQKF | 191 | Q7Z6M2 | |
| LCFAVRQEQVILQNC | 561 | Q8N3T1 | |
| NQKRQKCRWRQCLQF | 366 | Q9UIS9 | |
| LSRRCRCKFNQQQRT | 56 | O00168 | |
| QKSPNVLLQNLCCRI | 6 | Q96CW5 | |
| CVNEERRLQKQVCNV | 881 | Q9UKX5 | |
| QIQSREVQRKAFCTC | 226 | Q96R45 | |
| LQNEICCQLIKQTRR | 1016 | Q8IVE3 | |
| CCQLIKQTRRRQPQN | 1021 | Q8IVE3 | |
| LLIRFLCCSQQQKAT | 246 | P35410 | |
| VTRQVAQCKCAKRFQ | 7126 | Q9UPN3 | |
| KNENCSIVRINRNRC | 171 | P20393 | |
| SIVRINRNRCQQCRF | 176 | P20393 | |
| NRNRCQQCRFKKCLS | 181 | P20393 | |
| VKLRQSIRTVLFNQC | 126 | Q96IV6 | |
| AQRLEVQQCRASCKL | 471 | H7BZ55 | |
| KAACQRNRAVCQLLV | 1001 | O75912 | |
| RIYRCRNCINLQNEA | 621 | Q8NA54 | |
| ICQSNLQLVRARFCT | 686 | Q13683 | |
| TCLLCVSQKQLFLNR | 366 | Q5TBA9 | |
| RACQQFLKQCQLRSF | 101 | Q6UXB2 | |
| TQCFECIKTIQQRNL | 66 | Q8IWZ4 | |
| FLVRKSNTRQCQALC | 91 | Q13671 | |
| CAQRQLQLEQSLRVC | 21 | Q7L2K0 | |
| VQLLKRQSCPCQRND | 226 | Q9HB63 | |
| INLLNNAIRLKFQNC | 121 | Q12769 | |
| FIRNLCQKRHVCIQS | 386 | Q8N5C6 | |
| QRCKTRNRYICQFAQ | 431 | Q6UXF7 | |
| SLLCKCNRQLCQNRV | 346 | Q96T68 | |
| RTQAQQVLFNTCRCK | 81 | Q8TC36 | |
| RLRKLAQQIANCKQC | 291 | O15344 | |
| RNLLIVFKRCCNSQV | 2421 | O60281 | |
| QRCQFLDDRILQCIK | 811 | P53804 | |
| CCQRTKPQSFQVILQ | 1041 | Q92797 | |
| QRAIVRCQTCKINLC | 86 | Q9HBF4 | |
| CVNDRKKQLRQLFCS | 416 | Q3SXZ7 | |
| QCFECLKTTQQRNLK | 51 | C9J1S8 | |
| SKQTHRILQLNCCIQ | 391 | Q6UXY8 | |
| RILQLNCCIQCLNSI | 396 | Q6UXY8 | |
| KLRKLAQQVANCRQC | 311 | Q9UJV3 | |
| NCRQCLERSTVLINQ | 321 | Q9UJV3 | |
| TQRLLCQKKRFQCSE | 236 | Q6IV72 | |
| RCFQCQTKLELVQQE | 156 | Q9H8U3 | |
| CQQLVRCFCGRLVKQ | 36 | Q96QT4 | |
| NCKLQNLRLKRCRIS | 741 | P59046 | |
| LNDKAFIQQCIRQLC | 86 | O14777 |